Ameliorated Pap Tests and Cervical Cancer Screening Participation
Recruiting
N/A
Interventional Study
Cervical Cancer Screening
Cervical Cancer Screening Methods
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 25 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 248 (estimated)
- Sponsor
- National Taiwan University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Pap test plays a crucial role in the early detection of cervical cancer. A pilot single-center randomized controlled trial applied the peak-end concept and added a non-painful step at the end of Pap smear screening, aimed to reduce recalled pain. However, there is still no multicenter study investigating the effect of the modified Pap test on cervical cancer screening participation.
The prese…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women aged 25 or above
Exclusion Criteria:
* Ongoing menstruation
* Pregnancy
* Incapability of understanding the numeric pain scales
* Any active cancer at study entry (defined as cancer diagnosed or treated within the previous 6 months, recurrent, regionally advanced or me…
Contacts